Sign in to view content

Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results

Pravin U. Dugel, MD

Video
Published 2018

Related

Maximum Consecutive Fluid Free Months and Its Association With Visual and Anatomical Outcomes in nAMD: A Post-Hoc Analysis From HAWK and HARRIER
David A. Eichenbaum, MD, FASRS
Annual Meeting Talks
2021
Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results
Sam E. Mansour, MD, MSc,FACS, FRCS(C)
Annual Meeting Talks
2018
Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies
David M. Brown, MD
Annual Meeting Talks
2021

Category: AMD-Neovascular

See more